Pittsburgh Attorneys for Zantac® Cancer Lawsuits
Helping Clients Injured by Ranitidine Win Compensation
In September of 2019, the U.S. Food and Drug Administration (FDA) began testing ranitidine, the active ingredient in many heartburn medications, including Zantac®. The preliminary tests found low levels of n-Nitrosodimethylamine (NDMA), which has been classified as “probably carcinogenic to humans,” by the World Health Organization (WHO).
What is NDMA?
NDMA is an environmental contaminant that can appear in food and drinking water. It was previously used to make rocket fuel and is listed on the Center for Disease Control and Prevention’s (CDC’s) Toxic Substance Portal. While some exposure to NDMA is inevitable, the Agency for Toxic Substances and Disease Registry (ATSDR) recommends limiting the chemical’s concentration in water and other substances.
An initial alert by Valisure pharmacy warned of “extremely high levels of NDMA” in ranitidine medications.
How Does NDMA Appear in Heartburn Medicine?
Zantac® and many other ranitidine heartburn meds have been taken off the market while the FDA investigates NDMA concentrations. In Canada and France, the distribution of ranitidine drugs has been discontinued altogether. Health Canada (the Canadian equivalent of the FDA) has stated:
“Current evidence suggests that NDMA may be present in ranitidine, regardless of the manufacturer.”
NDMA typically enters medications during flaws in the manufacturing process, which means Sanofi, the maker of Zantac®, and other manufacturers may be responsible for increasing the risk of cancer among their consumers.
If you have developed cancer after taking Zantac® or a generic ranitidine medication, contact Robert Peirce & Associates, P.C. today.
The Risks of Long-Term Exposure
In order to cause adverse effects, NDMA must build up within the body. Fortunately, Zantac® and other heartburn medications are typically recommended for short-term use. Heartburn, however, is a common problem within the United States, and many ranitidine medications are sold over the counter; without the guidance of a prescription.
To limit their liability, pharmacy chains like CVS and Walgreens have suspended the sale of Zantac® and generic ranitidine drugs while the FDA investigates.
If you have been taking Zantac® or a similar medication for a long time, you should ask your doctor to switch your prescription, or discontinue over the counter use immediately.
Those who use the drug in moderation may continue to do so at their own risk.
Affected by Zantac®? Here’s What to Do:
If you have taken Zantac® or another ranitidine product, and experienced any adverse events or side effects as a result, be sure to report them to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program. Reports can be made online or at 1-800-322-1088.
If you have been diagnosed with cancer after taking Zantac® or any other drug containing ranitidine, get in touch with our attorneys ASAP.
Why File a Claim?
Treating cancer can cost upwards of $150,000. If there is any chance that a medication caused your illness, you should not have to face this huge financial burden alone.
Our ranitidine lawsuit attorneys can help uncover the cause of your ailment and hold drug manufacturers like Sanofi liable for any losses or expenses associated with your diagnosis.
Heartburn relief should never cost you your health, nor your life, especially when negligent manufacturing is to blame.
So far, no victims have come forward publicly and no verdicts or settlements have been awarded.
By filing a lawsuit against Sanofi or another ranitidine manufacturer, you can not only prepare yourself for treatment, but also inspire others to hold corporations accountable.
Get started with a free, confidential case evaluation today.
Help is one phone call away, and we are available 24/7 at (844) 383-0565.